News & Stories

The Hong Kong University of Science and Technology (HKUST) has shone in the second round of Research, Academic and Industry Sectors One-plus (RAISe+) Scheme launched by Innovation and Technology Commission’s (ITC), securing grants for seven teams – the highest number among local institutions.  The seven funded projects encompass a diverse array of innovative research and development efforts. Three projects focus on health and medical innovation, addressing areas spanning diagnostics, medical treatment and gene therapy.  Three others focus on AI chips, semiconductors and their materials, while the remaining one explores novel displays and optoelectronic technology.

The Hong Kong University of Science and Technology (HKUST) and AstraZeneca Hong Kong (AstraZeneca) today announced the signing of a Memorandum of Understanding (MoU) to build on their long-standing partnership, aiming to accelerate research and development (R&D) and drive innovation in the city’s life sciences ecosystem. The signing ceremony was held at the HKUST Unicorn Day 2025, an occasion where entrepreneurs, investors, and industry leaders come together for technological knowledge exchange and collaboration. Witnessed by President of HKUST and the Morningside Professor of Life Science, Prof. Nancy Ip and General Manager of AstraZeneca Hong Kong and Macau Ms. Shan Wu, the MoU was officially signed by Vice-President for Research and Development at HKUST, Prof. Tim Cheng and Head of Medical Affairs, BioPharmaceuticals & Rare Disease of AstraZeneca Hong Kong Mr. Tin Hung Wong.  

The Hong Kong University of Science and Technology (HKUST) has emerged as the top-performing local institution in the second round of the Innovation and Technology Commission’s (ITC) Research, Academic and Industry Sectors One-plus (RAISe+) Scheme, securing funding for seven projects. Spanning health and medical sciences, artificial intelligence (AI) and robotics, advanced manufacturing, and electrical and electronic engineering, these projects underscore HKUST’s leadership in transforming pioneering research into real-world applications.

The Hong Kong University of Science and Technology (HKUST) announced today that  its School of Engineering researchers have developed Mixture of Modality Experts (MOME), a groundbreaking large artificial intelligence (AI) model for non-invasive breast cancer diagnosis. Trained on the China’s largest multiparametric MRI (mpMRI) breast cancer dataset, MOME achieves expert-level accuracy in classifying tumor malignancy, comparable to that of radiologists with five+years of experience. This innovative solution is now undergoing extensive clinical validation across more than ten hospitals and partner institutions, including Shenzhen People’s Hospital, the Guangzhou First Municipal People's Hospital, and Yunnan Cancer Center, to validate its effectiveness and ensure real-world applicability. Harnesses China’s largest mpMRI Dataset

The Hong Kong University of Science and Technology (HKUST) showcased its groundbreaking advancements in medical technology and thought leadership at the 2025 Asia Summit on Global Health (ASGH) today.  As the event’s exclusive Thematic Session and Health Innovation Partner, HKUST highlighted how technology and collaboration can create a more equitable and sustainable healthcare system for hundreds of participants, including policymakers, healthcare experts, industry leaders, start-ups and investors from around the globe.  

The Hong Kong University of Science and Technology (HKUST) is receiving advisory support from Imperial College London (Imperial) and engaging with the University of California San Diego (UC San Diego) to pursue the establishment of the city’s third medical school, advancing medical education and clinical training. Echoing the government’s vision of building a third medical school that nurtures more doctors to meet the local demands and assists Hong Kong’s development into an international health and medical innovation hub, HKUST believes that new generations of doctors must possess the ability to serve and lead within the local context and leverage cutting-edge advancements in the global landscape of health and research. 

The Hong Kong University of Science and Technology (HKUST) has recently established strategic partnership with The First Affiliated Hospital of Sun Yat-sen University (FAH-SYSU), Southern Medical University (SMU), and Guangzhou Medical University (GMU) respectively. These individual partners will engage in in-depth collaboration with HKUST on areas such as clinical education, talent cultivation, medical research, and translation of innovations, injecting new impetus into the advancement of medical education and healthcare services.

The Hong Kong University of Science and Technology (HKUST) has signed a Memorandum of Understanding (MoU) with Microsoft Research Asia to enhance collaboration in medical health education and research. Focusing on three strategic areas – nurturing talent, revolutionizing smart healthcare, and developing enabling research – the MoU strives to drive the future collaboration of medical education through a holistic approach.